How Tiktok and Google Ended up With Information About Doctors’ Appointments Around the World
Keeping Journalism in Russia’s Orbit. Guerrilla Reporters, Data Journalism, and Vpns
“At a Certain Level of Exposure, ‘Free Palestine’ Becomes too Much of a Risk”
Softbank Confirms $50 Million Donation to Trump Library Just Two Months Before Trump’s Announcement of a Lease for Company’s Data Center
Bernie Sanders Reintroduces Bill to Make 32-Hour Workweek New Federal Standard
The Bond Market Is Flipping Out. Here’s Why You Should Care
Ukraine Launches ‘Vivaldi’ Counteroffensive in Donetsk
Trump has Turned an Unfixable Fact—Chinese Parts in Nearly Every U.S. Voting Machine—Into a License to Contest any Election it Loses
Putting a 3% tax on Billionaires' Wealth Could Save up to 29.5 Million Lives Among the Most Vulnerable Populations by 2030
Numbers are in on Trump’s Convention Audience — and it’s bad News for GOP
How Tiktok and Google Ended up With Information About Doctors’ Appointments Around the World
Keeping Journalism in Russia’s Orbit. Guerrilla Reporters, Data Journalism, and Vpns
“At a Certain Level of Exposure, ‘Free Palestine’ Becomes too Much of a Risk”
Softbank Confirms $50 Million Donation to Trump Library Just Two Months Before Trump’s Announcement of a Lease for Company’s Data Center
Bernie Sanders Reintroduces Bill to Make 32-Hour Workweek New Federal Standard
The Bond Market Is Flipping Out. Here’s Why You Should Care
Ukraine Launches ‘Vivaldi’ Counteroffensive in Donetsk
Trump has Turned an Unfixable Fact—Chinese Parts in Nearly Every U.S. Voting Machine—Into a License to Contest any Election it Loses
Putting a 3% tax on Billionaires' Wealth Could Save up to 29.5 Million Lives Among the Most Vulnerable Populations by 2030
Numbers are in on Trump’s Convention Audience — and it’s bad News for GOP

Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum

LA JOLLA, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will be participating in a fireside chat at Stifel’s 2026 Virtual Immunology and Inflammation Forum on Wednesday, September 23, 2026 at 12:00pm EDT.

Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.

A live webcast of the fireside chat may also be accessed on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. A replay of the webcast will be available for approximately 45 days following the conference.

About Equillium
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com.

Investor Contact
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.